Fervent Synergies Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fervent Synergies Limited with three other
pharmaceutical manufacturers in Asia:
Gujarat Themis Biosyn Limited
sales of 410.50 million Indian Rupees [US$5.79 million]
Piramal Phytocare Ltd
(251.20 million Indian Rupees [US$3.54 million]
Source Natural Foods and Herbal Supplements Ltd
(128.07 million Indian Rupees [US$1.81 million]
Sales increased substantially in 2019:
During the year ended March of 2019, sales at
Fervent Synergies Limited were 166.67 million Indian Rupees (US$2.35 million).
increase of 202.6%
versus 2018, when the company's sales were 55.07 million Indian Rupees.
Despite this increase, sales are still
below the level achieved in 2017, when Fervent Synergies Limited
reported sales of 391.46 million Indian Rupees.